Monthly Archives: December 2012

Wrestling with Agitation: Alexza’s Alternative

While the cognitive and negative symptoms of schizophrenia are now a major chronic care issue, the positive symptoms often return as the acute-care focus when patients, due to medication noncompliance and/or the fluctuating intensity of their illness, become agitated, with … Continue reading

Posted in Uncategorized | Leave a comment

Pimavanserin and Persistence

Acadia Pharmaceuticals is one of the very few survivors from the generation of neuropharm companies born in the early-mid 1990s. As is the case for many small firms, their prospects, were eventually and essentially condensed into one project, pimavanserin, a … Continue reading

Posted in Uncategorized | 1 Comment